Zealand Pharma Total Assets 2017-2021 | ZEAL

Zealand Pharma total assets from 2017 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Zealand Pharma Annual Total Assets
(Millions of US $)
2020 $270
2019 $240
2018 $195
2017 $112
2016 $103
Zealand Pharma Quarterly Total Assets
(Millions of US $)
2021-09-30 $263
2021-06-30 $312
2021-03-31 $352
2020-12-31 $270
2020-09-30 $323
2020-06-30 $336
2020-03-31 $231
2019-12-31 $240
2019-09-30 $255
2019-06-30 $185
2019-03-31 $206
2018-12-31 $195
2018-09-30 $238
2018-06-30 $84
2018-03-31 $102
2017-12-31 $112
2017-09-30 $131
2017-06-30 $56
2017-03-31 $68
2016-12-31 $103
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.907B $0.054B
Zealand Pharma A/S is a biotechnology company. It focused on the discovery, design and development of peptide-based medicines. Zealand Pharma A/S is based in Copenhagen, Denmark.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $125.010B 7.90
Bio-Rad Laboratories (BIO.B) United States $22.443B 45.55
QIAGEN (QGEN) Netherlands $12.357B 20.93
Biohaven Pharmaceutical Holding (BHVN) United States $6.783B 0.00
Arcus Biosciences (RCUS) United States $3.105B 0.00
Emergent Biosolutions (EBS) United States $2.254B 8.10
ADC Therapeutics SA (ADCT) Switzerland $1.478B 0.00
Myovant Sciences (MYOV) United Kingdom $1.368B 0.00
Zymeworks (ZYME) Canada $0.861B 0.00
Ambrx Biopharma (AMAM) United States $0.337B 0.00
SQZ Biotechnologies (SQZ) United States $0.319B 0.00
Enzo Biochem (ENZ) United States $0.162B 15.90